TGA statutory advisory committee and specialist advisor vacancies

16 September 2016

We are seeking expressions of interest from professionals with expertise in relevant scientific and medical fields or appropriate consumer issues to support our functions as a best practice regulator.

We are either seeking applications to become 'core' members on one or more of our statutory advisory committees or act as specialist expert advisors on specific topics.

As a committee member or expert advisor you will contribute significantly towards the TGA's regulatory functions by providing independent expert advice on specific technical matters relating to the regulation of medicines, devices, cell and tissue products and other substances.

Committee members provide advice on the therapeutic product life cycle, from premarket approval and access to post market product safety.

If you're interested in being involved with safeguarding and enhancing the health of the Australian community, have expertise in relevant clinical or scientific fields, or appropriate consumer issues, we would like to hear from you.

Proposed statutory committees

From January 2017, there will be seven statutory advisory committees that will provide independent advice to the TGA on specific clinical and scientific matters to aid regulatory decision making. The following statutory committees will be established or maintained:

  1. Advisory Committee for Medicines (ACM). The new ACM will encompass:
    1. the market authorisation advice role of the current Advisory Committee on Prescription Medicines;
    2. medicines safety advisory role of the current Advisory Committee on the Safety of Medicines; and
    3. provide advice as required on issues relating to over-the counter medicines (currently carried out by Advisory Committee on Non-Prescription Medicines).
  2. Advisory Committee on Complementary Medicines (ACCM).
  3. Advisory Committee for Devices (ACD). The new ACD will encompass:
    1. the market authorisation advice role of the current Advisory Committee on Medical Devices; and
    2. the devices safety advisory role of the current Advisory Committee on the Safety of Medical Devices.
  4. Advisory Committee for Vaccines (ACV).
  5. Advisory Committee for Biologicals (ACB).
  6. Advisory Committee on Chemicals Scheduling (ACCS).
  7. Advisory Committee on Medicines Scheduling (ACMS).

Appointments

Core committee members are appointed in an individual capacity to the TGA's statutory advisory committees by the Minister for Health. Appointments will be for either two or three year terms. Members may be required to attend three to six meetings a year.

Alternatively, as a specialist advisor, your expertise may be sought on specific topics. You will be appointed to our expert panel for three years. We understand that as an expert in your field your time may be limited so this opportunity allows for a more flexible contribution.

Remuneration committee members and expert advisors

Remuneration and travel for committee and expert advisors is in accordance with the latest Determination of the Remuneration Tribunal.

Committee-in-confidence obligations and requirement to declare all potential conflicts of interest

Members of TGA statutory advisory committees and expert advisors are bound by committee-in-confidence obligations as well as the need to declare all potential conflicts of interest. On appointment to a committee or as an expert advisor, you will be required to sign a Deed acknowledging the obligations of members and expert panel members in relation to confidential information and the requirements to disclose interests that may present a potential or actual conflict of interest to the committee's business. Please refer to the 'TGA advisory committee guidelines: Declarations of interests, managing conflicts of interests and confidentiality obligations'.

Privacy information

For TGA's general privacy information, see: Privacy.

  • Personal information is defined in the Privacy Act 1988 (Cth) (Privacy Act). Your personal information is protected by law under the Privacy Act, which contains Australian Privacy Principles. For more information see the Office of the Australian Information Commissioner website.
  • The TGA is a division of the Department of Health (Health)
  • Health's Privacy Policy contains information about:
    • how you may access your personal information and seek correction of it.
    • how you can complain about a breach of the Australian Privacy Principles and how Health will deal with that complaint.

The TGA collects personal information from you in order to administer your appointment or engagement as a TGA committee member and to communicate with you about committee business and processes. The TGA will disclose the basic biography of committee members on the TGA website.

Collection from statutory committee members of details of their personal or pecuniary interests is authorised by Part 6 of the Therapeutic Goods Regulations 1990.

Expressions of interest

You can submit an expression of interest via the TGA candidate portal. If you experience technical difficulties, your expression of interest (and all required documentation) can be submitted via email to committee.vacancies@tga.gov.au. Expressions of interest must be received by 4 October 2016.

Expressions of interest must include:

Enquiries can be made by email to committee.vacancies@tga.gov.au or please contact Dr Kaylene Raynes on (02) 6232 8334.

Expertise

General areas of expertise:

  • biostatistics;
  • blood and tissue products;
  • cellular therapies, including tissue engineering;
  • chemistry;
  • community  or clinical pharmacy;
  • consumer health issues;
  • epidemiology;
  • general medical practice in Australia;
  • intensive care;
  • manufacture of medicines;
  • medicines in pregnancy;
  • microbiology;
  • neurology;
  • nursing;
  • pharmacokinetics or clinical pharmacology; or
  • toxicology.

Specialist areas of expertise:

  • anaesthetics;
  • cardiology;
  • dermatology;
  • gastroenterology;
  • gerontology;
  • immunology;
  • infectious diseases;
  • internal medicine, including the following:
    • endocrinology;
    • haematology;
    • hepatology;
    • oncology;
    • rheumatology;
  • medical ethics;
  • medical genetics;
  • obstetrics and gynaecology;
  • ophthalmology;
  • paediatrics;
  • psychiatry;
  • renal disease;
  • respiratory medicine; or
  • developmental or reproductive toxicology.

General areas of expertise:

  • biomedical engineering or biomaterials;
  • consumer health issues;
  • epidemiology;
  • human factors analysis;
  • manufacturer of medical devices;
  • medical device software engineering;
  • toxicology; or
  • any other clinical or technical expertise that is appropriate to support the functions as set out in regulation 38A.

Medical or surgical expertise in one of the following fields:

  • anaesthetics;
  • biostatistics;
  • cardiology;
  • cardiothoracic surgery;
  • dentistry or oromaxillofacial surgery;
  • ear, nose and throat;
  • gastroenterology;
  • general medical practice in Australia;
  • gynaecology;
  • interventional cardiology;
  • interventional radiology;
  • neurology;
  • obstetrics and gynaecology;
  • ophthalmology;
  • orthopaedics;
  • pathology;
  • plastic and reconstructive surgery;
  • renal disease;
  • respiratory medicine;
  • vascular medicine; or
  • any other medical or surgical expertise that is appropriate to support the functions as set out in regulation 38A.
  • Chinese medicine;
  • complementary medical practice;
  • consumer health issues;
  • epidemiology;
  • general medical practice in Australia;
  • herbal medicine;
  • manufacture of medicines;
  • naturopathy;
  • nutrition and nutritional medicine;
  • pharmacognosy.
  • pharmacokinetics or clinical pharmacology; or
  • toxicology.
  • biostatistics;
  • blood and tissue products;
  • cellular therapies, including tissue engineering;
  • consumer health issues;
  • epidemiology;
  • infectious diseases; or
  • toxicology.
  • bacteriology;
  • biostatistics;
  • consumer health issues;
  • epidemiology;
  • immunology;
  • infectious diseases;
  • virology;
  • public health; or
  • vaccine program implementation.
  • consumer health issues relating to the regulation of medicines;
  • general medical practice in Australia;
  • industry issues relating to the regulation of therapeutic goods;
  • pharmacokinetics or clinical pharmacology;
  • pharmacy practice;
  • regulation of medicines in Australia; or
  • toxicology.
  • clinical aspects of human poisoning;
  • consumer health issues relating to the regulation of chemicals;
  • industrial or domestic chemicals;
  • industry issues relating to the regulation of chemicals;
  • occupational health, particularly as a medical practitioner;
  • regulation of chemicals in Australia;
  • the use of agricultural or veterinary chemicals;
  • toxicology; or
  • veterinary medicine or pathology.